Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Louisiana Attorney General Avandia Lawsuit

The Louisiana Attorney General filed a lawsuit accusing GlaxoSmithKline of wrongfully and illegally marketing, pricing, selling and promoting its Avandia diabetes drug. The state alleges that Louisiana’s Medicaid program paid GSK approximately $36 million since 1999 for fraudulently induced Avandia reimbursements. According to the state’s complaint: “GSK, at all times material hereto, orchestrated a campaign of misinformation concerning Avandia. The goal of that campaign was to maintain and maximize sales by concealing from Louisiana’s health care providers, prescribers, medical assistance programs, public health policymakers and Avandia-consuming diabetics, the numerous and grave adverse health effects, including, but not limited to heart attacks and deaths, caused by Avandia. GSK thus fraudulently priced, promoted and marketed Avandia so that Louisiana’s vulnerable diabetics would consume this, its more lucrative, profit-making drug, rather than employ less expensive and less life-threatening treatment for controlling their diabetes.”

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Pending
Date of Complaint
2/15/2011
Contractors Involved Penalty
Total
GlaxoSmithKline $0
Further Information Released
Complaint 3/5/2011
Louisiana AG Press Release 3/5/2011

Federal Contractor Misconduct Database